You need to be logged in to view this video
NeuroOne: Advancing Neuroscience with Disruptive Innovation
Released on Thursday, August 11, 2022•HEALTHCARE
NeuroOne will discuss its minimally invasive and high-definition/high-precision technology to monitor neural activity and treat various neurologic conditions. The company will present its products and discuss their potential to reduce costs, hospitalizations, and surgical procedures, and improve patient outcomes. Advancement of the company's development and commercialization milestones will also be addressed. Most recently, NeuroOne's Evo® sEEG Electrode saw its first clinical case at Emory University for intraoperative brain mapping at the subsurface level of the brain.
David Rosa
NeuroOne Medical Technologies Corporation,
President and CEO
David Rosa is president and CEO of NeuroOne. His background includes decades-long medical device experience and leading several early-stage medical device companies with CEO and senior positions at C.R. Bard Inc., Boston Scientific Inc., and St. Jude Medical. Mr. Rosa holds multiple medical patents.
Trending Now
Filter By Category
Filter By Keywords
Loading...